CY840A - Vaccine preparations containing adjuvants - Google Patents

Vaccine preparations containing adjuvants

Info

Publication number
CY840A
CY840A CY840A CY84072A CY840A CY 840 A CY840 A CY 840A CY 840 A CY840 A CY 840A CY 84072 A CY84072 A CY 84072A CY 840 A CY840 A CY 840A
Authority
CY
Cyprus
Prior art keywords
preparations containing
vaccine preparations
containing adjuvants
adjuvants
vaccine
Prior art date
Application number
CY840A
Other languages
English (en)
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of CY840A publication Critical patent/CY840A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CY840A 1971-03-26 1972-03-22 Vaccine preparations containing adjuvants CY840A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00128530A US3839555A (en) 1971-03-26 1971-03-26 Vaccine adjuvant and method

Publications (1)

Publication Number Publication Date
CY840A true CY840A (en) 1976-09-10

Family

ID=22435777

Family Applications (1)

Application Number Title Priority Date Filing Date
CY840A CY840A (en) 1971-03-26 1972-03-22 Vaccine preparations containing adjuvants

Country Status (9)

Country Link
US (1) US3839555A (enExample)
BE (1) BE781028R (enExample)
CA (1) CA980251A (enExample)
CY (1) CY840A (enExample)
DE (1) DE2214229A1 (enExample)
FR (1) FR2130132B2 (enExample)
GB (1) GB1327740A (enExample)
IN (1) IN139166B (enExample)
NL (1) NL7202698A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243663A (en) * 1976-06-25 1981-01-06 Ichiro Azuma Glycolipid compositions for transplanted tumor immunotherapy
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
US4761281A (en) * 1986-04-22 1988-08-02 Immunomed Corporation Vaccine from Dirofilaria extracts
DD298884A5 (de) * 1990-07-10 1992-03-19 Charite Der Humboldt-Universitaet,De Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung
DE4141970C2 (de) * 1991-12-16 1998-02-19 Charite Med Fakultaet Kombinationsimpfstoff gegen AIDS, Bilharziose und Tuberkulose und Verfahren zu seiner Herstellung
WO2005039597A2 (en) 2003-10-24 2005-05-06 N.V. Nutricia Immunemodulating oligosaccharides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1137540A (en) * 1966-12-20 1968-12-27 Nat Res Dev Improvements relating to the treatment of hypocalcaemia
CA928218A (en) * 1969-06-17 1973-06-12 Recherche Et Industrie Therapeutiques R.I.T. Antiinfectious compositions and process for their preparation

Also Published As

Publication number Publication date
CA980251A (en) 1975-12-23
NL7202698A (enExample) 1972-09-28
US3839555A (en) 1974-10-01
GB1327740A (en) 1973-08-22
DE2214229A1 (de) 1972-09-28
IN139166B (enExample) 1976-05-15
FR2130132A2 (enExample) 1972-11-03
BE781028R (fr) 1972-09-22
FR2130132B2 (enExample) 1975-12-26

Similar Documents

Publication Publication Date Title
GB1372785A (en) Enemata administering devices
BE787901A (fr) Vaccin antivariolique
ZA724983B (en) Pharmaceutical preparations
AT315378B (de) Antitranspiranszubereitungen
CY840A (en) Vaccine preparations containing adjuvants
PH11066A (en) Hair preparation
GB1363182A (en) Toothpaste preparations
BE794307A (fr) Vaccin anti-caries
ZA72570B (en) Hair preparations
IL45870A0 (en) Vaccine preparations
ZA723683B (en) Improved effervescent preparations
ZA713029B (en) Oral preparations
ZA729156B (en) Vaccine adjuvants
ZA715544B (en) Vaccine preparation
IL37849A (en) Stable virus preparations
IL40597A0 (en) Antihypertensively pharmaceutical preparations
ZA743771B (en) Vaccine and preparation thereof
AU4173472A (en) Vaccine
IL32962A (en) Vaccine preparations
ZA723920B (en) New pharmaceutical preparations
PH9243A (en) Oral preparations
AT322091B (de) Impfgeraet
ZA724625B (en) Pharmaceutical preparations
ZA721170B (en) New pharmaceutical preparations
ZA721169B (en) Pharmaceutical preparation